← Open Payments lookup

KEMBA BANYARD: Open Payments

NPI 1295080521 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,955 in 132 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,107 · 2025 $2,955

Food & beverage: $2,912Education: $42
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.31$634
Otsuka America Pharmaceutical, Inc.18$471
Lundbeck LLC30$445
Janssen Pharmaceuticals, Inc9$272
Tris Pharma Inc7$223
Novo Nordisk Inc6$188
Axsome Therapeutics, Inc.4$181
Lilly USA, LLC8$174
Teva Pharmaceuticals USA, Inc.7$139
Collegium Pharmaceutical, Inc.4$82

Products named: REXULTI, FANAPT, INVEGA SUSTENNA, Dyanavel XR, Wegovy, Auvelity, MOUNJARO, ABILIFY ASIMTUFII.

Industry payments across WI — which companies pay providers there.